• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Integer Holdings Corp (ITGR)

Equity
Sell: $50.78|Buy: $203.10|Change: 4.15 (3.38%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

Address

5830 Granite Parkway
Suite 1150
Plano
TX
USA
75024

Telephone

+1 763 9518312

Website

https://www.integer.net

Sector 

Healthcare

Forecast key dates

NameKey Date
Integer Holdings Corp First Quarter Earnings Conference Call for 20262026-04-24T09:00:00
Integer Holdings Corp First Quarter Earnings Results for 20262026-04-24T00:00:00
Integer Holdings Corp Fourth Quarter Earnings Conference Call for 20252026-02-20T09:00:00
Integer Holdings Corp Fourth Quarter Earnings Results for 20252026-02-20T08:00:00
Integer Holdings Corp Annual Report for 20252026-02-20T00:00:00
Integer Holdings Corp Third Quarter Earnings Conference Call for 20252025-10-24T09:00:00
Integer Holdings Corp Third Quarter Earnings Results for 20252025-10-24T08:00:00
Integer Holdings Corp Second Quarter Earnings Conference Call for 20252025-07-25T09:00:00
Integer Holdings Corp Second Quarter Earnings Results for 20252025-07-25T08:00:00
Integer Holdings Corp Annual General Meeting for 20252025-05-22T09:00:00
Integer Holdings Corp First Quarter Earnings Conference Call for 20252025-04-24T09:00:00
Integer Holdings Corp First Quarter Earnings Result for 20252025-04-24T00:00:00

Previous key dates

NameKey Date
Integer Holdings Corp First Quarter Earnings Conference Call for 20252025-04-24T09:00:00
Integer Holdings Corp First Quarter Earnings Result for 20252025-04-24T00:00:00
2025 KeyBanc Capital Markets Healthcare Forum2025-03-19T09:45:00
2025 Raymond James & Associates' 46th Annual Institutional Investor Conference2025-03-05T11:00:00
Integer Holdings Corp Fourth Quarter Earnings Conference Call for 20242025-02-20T09:00:00
Integer Holdings Corp Fourth Quarter Earnings Results for 20242025-02-20T08:00:00
Integer Holdings Corp Annual Report for 20242025-02-20T00:00:00
the Piper Sandler 36th Annual Healthcare Conference2024-12-03T10:30:00
Integer Holdings Corp Third Quarter Earnings Conference Call for 20242024-10-24T09:00:00
Integer Holdings Corp Third Quarter Earnings Results for 20242024-10-24T08:00:00
Wells Fargo 2024 Healthcare Conference2024-09-04T14:15:00
Integer Holdings Corp Second Quarter Earnings Conference Call for 20242024-07-25T09:00:00
Integer Holdings Corp Second Quarter Earnings Results for 20242024-07-25T08:00:00
2024 Truist Securities MedTech Conference2024-06-18T13:55:00
Integer Holdings Corp Annual General Meeting for 20242024-05-22T09:00:00
Integer Holdings Corp First Quarter Earnings Conference Call for 20242024-04-25T09:00:00
Integer Holdings Corp First Quarter Earnings Result for 20242024-04-25T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.